Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF
about
The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1.Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator TatExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidThe transcription factor LSF: a novel oncogene for hepatocellular carcinomaYY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infectionIdentification of genes conferring resistance to 5-fluorouracilDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyTargeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.Latency reversal and viral clearance to cure HIV-1.Control of stochastic gene expression by host factors at the HIV promoter.The cellular protein daxx interacts with avian sarcoma virus integrase and viral DNA to repress viral transcription.Combinatorial latency reactivation for HIV-1 subtypes and variantsErythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family.Statistical significance of clusters of motifs represented by position specific scoring matrices in nucleotide sequencesEfficient and specific targeting of Polycomb group proteins requires cooperative interaction between Grainyhead and Pleiohomeotic.Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activationAn upstream YY1 binding site on the HIV-1 LTR contributes to latent infection.Modeling the Effects of Vorinostat In Vivo Reveals both Transient and Delayed HIV Transcriptional Activation and Minimal Killing of Latently Infected Cells.Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSFValproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.HIV-1 Latency and Eradication: Past, Present and FutureMolecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Reactivation of latent HIV by histone deacetylase inhibitors.HIV latency and integration site placement in five cell-based models.Mechanisms of HIV Transcriptional Regulation and Their Contribution to LatencyMammalian transcription factor LSF is a target of ERK signaling.Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.
P2860
Q24525309-EC5CC254-1935-4427-8EB4-F718D06F933BQ24537275-B4F9CFE4-1E84-4DE2-A055-0AE67A1BFBEFQ24596282-68E240AB-1433-4BD4-8E03-CB1F92174A9BQ24613885-8045566E-68F8-48EB-96C2-EE70A77081FAQ24646624-5C2638F6-B860-43CD-9BF0-0FE90138C1B9Q24655818-A57A76DF-A654-4CFD-BE9D-4F7621E0391DQ28111910-3863E562-DB49-480D-B3D4-1B0B5814896FQ28213125-5A9A987A-F633-4FC0-AC59-8A1EE435E4C8Q30248766-BCF80C39-8C32-40F1-BE6E-D5819D98EA21Q33398516-34813AB8-581A-47CD-B3AC-EF54E8690A55Q33724291-77FE202A-1740-4459-9461-3E5D8EDAF021Q33877492-1C1C12BE-AF97-4623-91B1-A7F35C8CD3B2Q33884209-D1C5828A-3197-4E48-BDC7-9D844A92395CQ34327872-4CBE737F-E318-4337-9DC1-63448585F8BCQ34353564-F57FBF3D-1776-4638-9554-DA6735EACF24Q34647406-B711D708-5A24-4BA2-B750-6DA0EE3EACB9Q35015033-20EBC349-64AF-43FF-83B1-4193D50A96CEQ35819184-DB600B48-2033-40D9-BB3A-70E670F62270Q35962753-C88022D4-A6E2-48C5-982A-795FD3C65F3EQ37393518-C065A545-12E3-42E6-9BEE-B13F5B457DFFQ37505823-68C996BA-1A29-4949-AB37-D181787A55DDQ37644561-2A2E3E02-3DD2-47F5-B25B-620599935636Q38091753-A54D93BA-E64C-4C17-BE31-F0D40519BF4FQ39109122-048F7C6D-09D1-40D6-AE52-FBCE2AB1219CQ41769072-F4D2CA62-68D6-4856-AFF4-D81CA4B86D44Q41825990-40E1F9FC-3E6B-4356-83F6-4A9C94F20D2EQ42732128-387DA6C8-58CF-4518-8015-DBEE0E631B36Q47555946-4F2AE95D-996C-4B30-8C6B-FCD2C57AA074
P2860
Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Repression of human immunodefi ...... n of human factors YY1 and LSF
@ast
Repression of human immunodefi ...... n of human factors YY1 and LSF
@en
Repression of human immunodefi ...... n of human factors YY1 and LSF
@nl
type
label
Repression of human immunodefi ...... n of human factors YY1 and LSF
@ast
Repression of human immunodefi ...... n of human factors YY1 and LSF
@en
Repression of human immunodefi ...... n of human factors YY1 and LSF
@nl
prefLabel
Repression of human immunodefi ...... n of human factors YY1 and LSF
@ast
Repression of human immunodefi ...... n of human factors YY1 and LSF
@en
Repression of human immunodefi ...... n of human factors YY1 and LSF
@nl
P2093
P2860
P1433
P1476
Repression of human immunodefi ...... n of human factors YY1 and LSF
@en
P2093
Gabriel MN
Margolis DM
P2860
P304
P407
P577
1997-12-01T00:00:00Z